KalVista Pharmaceuticals Acquired by Chiesi Farmaceutici | Healthcare M&A Deal

Chiesi Farmaceutici has acquired KalVista Pharmaceuticals, a pharmacy business in Massachusetts, for $49M. KalVista Pharmaceuticals develops specialty medicines, supporting a pharmacy acquisition strategy for Chiesi Farmaceutici acquisitions in healthcare M&A. The merger acquisition targets growth in MA acquisitions by adding KalVista’s drug pipeline and commercial capabilities to Chiesi’s portfolio. The strategic acquisition is structured as a merger acquisition via Skyline Merger Sub, Inc., a wholly owned subsidiary of Chiesi Farmaceutici S.p.A., with a cash price of $27.00 per share, net to the seller, and an announced tender offer process.